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SUMMARY 
Objectives:  To estimate the reference intervals for 
commonly used blood haematology and biochemical 
parameters in an adult (18-55yrs) population of resi-
dents of Mampong Akuapem.   
Design:  This was a population based cross sectional 
study of a randomly selected sample of the adult popu-
lation of Mampong.  The sample was selected from an 
updated census list of the Mampong area.    
Results:  Median values (95% range) for measured 
parameters were established as follows: Haemoglobin, 
(males) 14.2 g/dl (females) 12.0 g/dl Alanine  ami-
notransferase  (ALT), (female) 19.6 U/L (males) 26.1 
U/L and Creatinine, (males) 108 mmol/L (females) 93 
mmol/L.   
Conclusion:  In comparison to reference values that 
are commonly used in Ghana, the haemoglobulin levels 
from this study were lower, and liver function parame-
ters higher. This could be a result of genetic or envi-
ronmental differences and calls for the need to estab-
lish site specific reference values applicable to our 
population 
 
Keywords: Reference ranges, blood chemistry, blood 
haematology, Ghana.   
 
INTRODUCTION 
Reference values (or normal values) for haematologi-
cal and biochemical parameters are used to aid physi-
cians to interpret results of clinical measurements. 
They may also be used in clinical trials as a guide to 
setting inclusion / exclusion criteria as well as the basis 
of safety monitoring for trial participants. Reference 
values for African populations are not readily available 
and the values used in Ghana are usually based on re-
sults of measurements in advanced countries, taken 
from the literature (of advanced countries) or from 
package inserts that accompany reagent kits.  How-
ever, these parameters even in the healthy state are 
affected by several factors including age, ethnicity1, 2 
gender and environment (including altitude).3 The few 
studies that have been undertaken have indicated dif-
ferences in normal values of African populations, even 
in children and adolescents, compared to those derived 
from industrialized populations, especially for haema-
tologic indices.3 These differences may suggest the 
need for the development of locally derived reference 
values (for these parameters) to improve clinical care 
and also for monitoring participants in clinical trials. In 
establishing reference values, it is essential that the 
population is well defined and properly selected to be 
representative of that population, as the lower and up-
per limits of measurements are known to be more af-
fected by the choice of the sample population, stan-
dardization of the sample collection and handling and 
analysis and  also the statistical analysis4,5.  Several 
novel malaria vaccine candidates that have been tested 
in non endemic populations are entering clinical trials 
in endemic countries to assess safety as part of the 
clinical development of these products.  
 
In Ghana, the Noguchi Memorial Institute for Medical 
Research (NMIMR), with support from National Insti-
tute of Allergy and Infectious Disease (NIAID) in the 
USA, has over the past 5 years been developing poten-
tial sites for malaria vaccine trials and it is envisaged 
that we will be conducting some of these trials in the 
near future. Prior to initiating any trial, it is imperative 
to establish the normal range of values for the labora-
tory indices that will be used to screen potential volun-
teers to determine if they meet the inclusion / exclu-
sion criteria as well as assess vaccine safety in those 
volunteers who receive the test product. The Noguchi 
Memorial Institute for Medical Research is currently 
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involved in preparatory studies to gather background 
data needed for the efficient conduct of malaria vac-
cine trials.  We report here the results of one such 
study undertaken to establish the distribution of values 
for specific haematological and biochemical parame-
ters in the adult population of Mampong Akuapem, a 
site intended for a phase I malaria vaccine trial.   
 
MATERIALS AND METHODS 
Study Site 
Mampong town is located in the Akuapem North dis-
trict in the Eastern Region of Ghana about 35 km north 
east of Accra.  It lies on the Akuapem-Togo mountains 
range, with an elevation ranging  between 381m and 
487.7 m above sea level.    The spoken language in 
Mampong is Twi, the major occupation is farming, 
although a substantial proportion of individuals work 
in the district offices, hospital and also the several 
schools in the district. Health services are provided by 
the Tetteh Quarshie Memorial Hospital, the Centre for 
Scientific research into Plant Medicine, and also by 
some private clinics and traditional healers. Malaria 
transmission occurs year round, and was the number 
one cause of hospital admission in the district for 
20026.  It is also the leading cause of out-patient atten-
dance at the Tetteh Quarshie Memorial Hospital7.   
 
The total population of Mampong is 7,733 residents in 
1957 households giving an average household size of 4 
persons.  Females formed a slightly higher proportion 
of the population (54.55 %) and the population 18years 
and above comprise approximately 50%. We sampled 
from approximately 3500 individuals aged between 18 
and 55 years, resident in 5 out of 10 enumeration areas 
chosen to represent the various sectors of the town. 
The list was obtained from an updated census listing 
prepared by the Ghana Statistical Service. Selected 
individuals were approached to obtain consent to par-
ticipate in the study after a thorough explanation of the 
study had been presented to them.  Those agreeing to 
participate were then enrolled into the study.   
 
Study Design  
This was a cross sectional study of a representative 
sample of the adult population of Mampong to deter-
mine reference ranges of common haematological and 
biochemical parameters. According to the United 
States National Consensus Committee on Laboratory 
Standards, NCCLS Guidance Document C28A2, for 
most analytes the lower and upper reference limits are 
assumed to demarcate the estimated 2.5th and 97.5th 
percentiles of the underlying distribution of values.4, 8 
For general standard practice, to estimate these limits 
with 95 % confidence a minimum sample size of 120 
from each sample group (e.g. Males and Females) is 
recommended, assuming the use of the nonparametric 
method of analysis. This minimum sample size also 
allows the estimation of 90% confidence interval for 
each reference limits.  This number assumes no losses 
or deletion of observations, so to allow for 10 % 
losses, the targeted total sample size was 264 volun-
teers (132 males, 132 females). 
 
Volunteer recruitment and Sampling strategy: 
Previous contact with the population in Mampong fa-
cilitated the informed consent process. Recruitment 
efforts included discussions with opinion leaders in the 
community and a durbar to educate the population 
about the objectives of the study.  
 
The primary aim was to get a sample that represented 
the target population; and to achieve that a two-stage 
sampling method was employed. The sampling frame 
was the updated list of Enumeration Areas (EA’s) in 
the Mampong area that was used for the 2000 national 
population census by the Ghana Statistical Services9.  
Mampong town was divided into 3 broad areas, the 
northern part (around the hospital), the central part 
encompassing the centre of the town and the southern 
part.  At the first stage a random sample of 5 EA’s was 
chosen from the sampling frame.  An updated listing of 
all households in the selected EA’s was then compiled.  
Subsequently the list of individuals in each household 
was updated and those between 18years and 55 years 
were invited to join the survey.  Each individual was 
approached and asked if s/he would like to participate 
in the study and enrolment continued until at least 264 
participants (132 females and 132 males) had been 
sampled.  An a priori sampling method was used 
where individuals had to meet well-defined exclu-
sion/inclusion criteria before being selected as a refer-
ent individual. 
 
Consenting individuals were screened with a history 
and physical examination to rule out any obvious in-
tercurrent disease.  Females had a urine dipstick ex-
amination for the presence of β-HCG hormone.  Par-
ticipants were included in the study only if they were 
aged between 18 and 55 years, generally of good 
health with no evidence of a chronic or acute illness on 
examination, resident in Mampong and agreed to take 
part as evidenced by the signing of the consent form. 
Females had to be non pregnant as evidenced by the 
absence of β-HCG hormone in a freshly voided urine 
sample.  Those clinically assessed to be healthy were 
then asked to donate a sample of venous blood (maxi-
mum of 10mls) and a sample of urine.  The urine was 
tested on site and the blood sample was collected in 
EDTA and Serum separator tubes, transported to 
NMIMR in cool boxes for haematological and bio-
chemical analysis.  The haematological analyses were 
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performed within 4 hours of blood draw.  Serum was 
separated from the blood after centrifugation and 
stored between 20C and 80C before analysis, which 
was completed within 24 hours of blood draw. 
 
Laboratory assays 
The following assays were performed on each blood 
specimen: The haematological assays were  performed 
using the automated haematology analyser KX-21, 
(Sysmex Coporation, Kobe, Japan) and these included: 
WBC and differential counts, MCV, MCH and 
MCHC, RBC, Haemoglobin concentration , Haema-
tocrit  and Platelet count. 
 
The following biochemical parameters were deter-
mined using the autohumalyser 900S Plus (Human 
GmbH, Diagnostica Worldwide, Germany): liver en-
zymes including Alanine aminotransferase, Aspartate 
aminotransferase (AST), Serum Bilirubin (total and 
direct) and indicators of renal function including, Urea 
and Creatinine and serum electrolytes (K+ and Na+) 
concentrations.  In addition all samples were screened 
for Haemoglobin S (HbS) by electrophoresis and thick 
and thin blood smears made and examined for the 
presence of malaria parasites by microscopy.  All the 
assays were performed according to Standard Operat-
ing Procedures (SOPs) written and maintained in the 
clinical laboratory of NMIMR. 
 
Data Management and Analysis 
Data entry and analysis were done using Epi Info 2002 
(CDC) and STATA 8.0 (Stata Corp, College Station, 
Tx). This is a descriptive study and reference intervals 
were determined using the methods described in the 
NCCLS guidelines (NCCLS 1992)4.  This assumes no 
prior distribution of the data. Non-parametric methods 
were used to determine the 2.5th and 97.5th centiles and 
the respective 90% confidence limits around these es-
timates using the binomial approximation.  The under-
lying assumption is that the 2.5th and 97.5th centiles 
will contain 95% of the distributions of normal values 
in the reference population. Extreme values were han-
dled by the method described in the NCCLS guidelines 
by doing a range check and the methods of Dixon 
(Dixon’s Test )4.  Briefly, the extreme values were 
retained in the distribution if the D/R < 0.33 where D 
is the absolute difference between the most extreme 
distribution and the next value and R is the Range 
(max – min).   
The reference intervals were calculated separately for 
men and women for analytes that were expected to be 
distributed differently between males and females on 
physiological grounds, or where there is a statistically 
significant difference between the mean values for 
males and females, and the difference is clinically sig-
nificant4,10.   
 
Ethics 
This was a minimal risk study and was conducted in 
accordance with the protocol and Good Clinical Prac-
tices to ensure protection of all aspects of the ethical 
rights and welfare of research participants.  The study 
followed the International Conference on Harmonisa-
tion of Technical Requirements for Registration of 
Pharmaceuticals for Human Use ICH Topic E 6 Guide-
line for Good Clinical Practice.   The study was ap-
proved by the Institutional Review Board of Noguchi 
Memorial Institute, the IRB of NMRC and the Study 




A total of 400 individuals aged between 18 and 55 
years were randomly selected from the sampling frame 
and were invited to take part in the study.  Of these 
356 (89%) consented to take part.   
 
Table 1a Reference haematological and biochemical intervals for males
 
 N Median 2.5th percentile 
(90% CI) 
97.5th percentile (90% 
CI) 
Hematology 













11.7 (11.2, 12.3) 
37.1 (34.3, 38.0) 
97 (57, 130) 
 
16.5 (16.3, 18.0) 
51.4 (49.9, 59.0) 
356 (318, 469) 
Liver Function 














11.6 (9.9, 12.3) 
18.7 (15.5, 20.4) 
 
478.9 (379.0, 536.1) 
53.1 (45.8, 65.1) 
65.0 (54.2, 92.2) 
Renal Function 






81.4 (79.0, 84.5) 
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Table 1b Reference haematological and biochemical intervals for females 
 
 N Median 2.5th centile (90% CI) 97.5th centile (90% CI) 
Haematology 
- Haemoglobin (g/dL) 
- Haematrocrit (%) 










9.1 (7.4, 10.2) 
29.1 (25.5, 32.4) 
118 (82, 138) 
 
14.0 (13.6, 14.4)  
43.6 (42.8, 45.2)  
385 (359, 629) 
Liver Function 
- Alkaline Phosphatase ( U/L) 
- ALT ( U/L) 










98.2 (92.2, 104.5) 
9.5 (6.7, 10.2) 
15.5 (14.8, 17.6) 
 
316.4(294.0, 376.9) 
39.2 (35.2, 44.4) 
46.5 (37.0, 80.3) 
Renal Function 






69.8 (68.9, 74.9) 
 
120.5 (115.3, 139.6) 
The major reason given for non participation was 
travel out of the study area at the intended time of 
blood sampling (in more than 85% of those not being 
able to participate).   
Of the 356 individuals, 313 (87.9%) were seen at the 
appointed time and of these 298 (95.2%) qualified to 
participate.  Of the 15 volunteers disqualified, 7 
(46.7%) were disqualified because they were pregnant 
(positive for β-HCG hormone), 3 each (20%) for hy-
pertensive heart disease and being outside the age 
range and 2 (13.3%) because someone else had signed 
their consent forms for them.   
 
The resultant study population comprised 156 females 
(52.3%) and 142 males (47.7%) with the females 
slightly older [mean age (s.d.) = 34.3 (10.7) yrs] than 
the males [mean age (s.d.) = 31.8 (11.4) yrs].  The 
prevalence of sickle cell trait (AS) and HbC trait (AC) 
was 20.1 % and 6.8 % respectively, with no significant 
difference between males and females. Prevalence of 
sub-clinical P. falciparum parasitaemia was 8.7%.  
 
Urinalysis (by dipstick) 
Analysis of freshly voided urine showed that the urine 
appeared cloudy more frequently in females (24.4%) 
compared to males (6.4%), [p<0.05]. Protein was de-
tected in approximately 20% of study participants, all 
positive results being in trace quantities only. Traces of 
blood were detected in approximately 10% of indi-
viduals. Although the frequency of occurrence was 
higher in females (12.9%) than in males (6.3%) the 
difference was not statistically significant. Glucose 
was detected in trace quantities in less than 2% of 
study participants.  
 
Haematological Parameters 
Box plots for haemoglobin, haematocrit and platelet 
counts by gender are shown in Figs 1a-1c. As ex-
pected, mean (95% CI) haemoglobin (Hb) concentra-
tions were significantly higher in males, 14.2 g/dL 
(14.0, 14.4) (Figure 1b) than in females 12.0g/dL 
(11.8, 12.2). The median Hb concentration for males 
was 14.2g/dL and the corresponding reference interval 
11.7 – 16.5 g/dL.   
For females the corresponding values were median 
12.0g/dL and reference interval, 9.1 – 14.0 g/dL (Ta-
bles 1a and 1b).  
 
Mean corpuscular volume (MCV), Mean corpuscular 
heamoglobin concentration (MCHC) and Red blood 
cell (RBC) all differed by gender. Platelet counts were 
higher in females, mean (95%CI) = 239× 103 /μl (227 
× 103, 250 × 103) than in males, mean (95% CI) = 213 
















F M  
 
Means (95% CI) for Females and Males = 37.5 (36.9, 38.0) and 44.0 (43.4, 
44.7) respectively, p = 0.001 
Figure 1a Distribution of Haematocrit 
 
The reference interval for Platelet count were reported 
as 118-385 × 103, median 233× 103 ( female)(Table 
1b) ; 97-356× 103, median 208× 103 ( male) (Table 1a). 
The White Blood Cell (WBC) count was not signifi-
cantly different for males and females. The median 
WBC count was estimated to be 5.6x109/L with a ref-
erence interval of 3.4 – 8.8x109/L. (Table 2) 
 
 













F M  
Means (95% CI) for Females and Males = 12.0 (11.8, 12.2) and 14.2 (14.0, 
14.4) respectively, p = 0.0001 























F M  
Means (95% CI) for Females and Males = 239 (227, 250) and 213 (203, 223) 
respectively, p = 0.0012 
Figure 1c Distribution of Platelet count 
 
Biochemical parameters 
The concentrations of the liver enzymes, ALT, AST 
and Alkaline Phosphatase and serum Creatinine were 
significantly higher in males than in females and based 
on this analysis, separate reference intervals for males 
and females were reported for these analytes.  
 
Mean (95% CI) concentration of ALT in females was 
19.6 IU/L (18.5, 20.7) compared to 26.1 IU/L (24.4, 
27.8) in males, (Fig. 2a) the reference values  for ALT 
were 11.6 – 53.1 U/L median = 24.3 U/L (male) (Table 
1a), 9.5 – 39.2 U/L, median = 18.0 U/L (female) 
 
The mean (95% CI) concentration of AST for females 
was 26.8 (25.5, 28.1) compared to 34.2 (32.2, 36.2) for 
males (figure 2a). The reference values for AST were 
(male) 18.7 – 65.0U/L median = 31.3U/L (Table 1a) 
and (female) 15.5 – 46.5 U/L, median = 25.7 U/L (Ta-
ble 1b).  
 
For serum Creatinine, the respective mean concentra-
tions in males and females were 108 U/L (105, 110) 









alanine amino transferase aspartate amino transferase
 
Means (95% CI) for Females and Males; ALT = 19.6 (18.5, 20.7) U/L and 
26.1 (24.4, 27.8) U/L respectively, p = 0.001. AST, = 26.8 (25.5, 28.1) U/L 
and 34.2 (32.2, 36.2) U/L respectively, p= 0.0001 
Figure 2a Distribution of ALT and AST 
 
  The median Creatinine concentrations for males and 
females respectively were 105mmol/L and 91mmol/L 
and the respective reference intervals were 81 – 
141mmol/L and 70 – 121mmol/L (for males and fe-















F M  
Means (95% CI) for Females and Males = 93 (91, 95) U/L  and 108 (105, 110) 
U/L respectively, p = 0.001 
Figure 2b Distribution of serum creatinine 
 
The mean (95% CI) concentration for Alkaline Phos-
phatase was 180 (171, 188) and 210 (197, 223) respec-
tively for females and males (Fig. 2c).  The reference 
interval for Alkaline Phosphatase was; (male) 124 – 
479 U/L, median = 194 U/L (Table 1a) and (female) 





















F M  
Means (95% CI) for Females and Males = 180 (171, 188) U/L and 210 (197, 
223) U/L respectively; p = 0.0002 
Figure 2c Distribution of Serum Alkaline Phosphatase 
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The distribution of Bilirubin, Albumin and Urea did 
not differ significantly between males and females. 
Mean (95% CI) Total Bilirubin concentration was 0.5 
mg/dL (0.4, 0.5), median = 0.4mg/dL, reference inter-
val 0.1–1.4mg/dL (Table 2). Mean (95% CI) for Serum 
Albumin was 5.6g/dL (5.6, 5.7), median = 5.6g/dL, 
reference interval 4.6 – 6.8g/dL (Table 2).  Mean (95% 
CI) Urea was 4.4 mmol/L (4.2, 4.6), median = 




The results of our survey indicate there are significant 
differences in the reference values for males and fe-
males in the following parameters of the adult popula-
tion of Mampong; hemoglobin, heamatocrit, platelet, 
Alkaline phosphatase, Alanine transaminase (ALT), 
Aspartate transaminase (AST) and Creatinine (Tables 
3a and 3b).   
 
The gender differences seen in heamatologic indices is 
a well established fact and has been similarly reported 
in other studies, men having a higher hemoglobin and 
heamatocrit level compared to women.3,11,12,13  
 
Females had a higher platelet count compared to men, 
comparable to a study which looked at ethnic and sex 
differences in WBC and platelet counts12,14.  Based on 
the results from this study, the haemoglobin level for a 
healthy male adult living in Mampong should be be-
tween 11.7 – 16.5 dl/g and that for a female, 9.1-14.0 
dl/g.  
 
These values are lower than the reference values 
quoted in the accompanying manual of the heamatol-
ogy analyzer used in the study, meaning a percentage 
of these adults could be misclassified as having a low 
haemoglobin level using the reference values that are 
often quoted.  Evidence from other studies have shown 
that haematological indices are significantly lower in  
populations of African origin as compared to standard 
reference values quoted in the literature for industrial-
ized countries, often applicable to Caucasians3,11. This 
difference could be due to environmental or genetic 
factors or a combination of both or to several other 
factors.  Such differences indicate the need to develop 
reference values that are appropriate for the applicable 
population.  
 
The transaminases, alanine aminotransferase (ALT) 
and aspartate aminotransferase (AST) are usually used 
as markers of hepatocyte injury and therefore are usu-
ally tracked in vaccine or drug trials for evidence of 
hepatic damage resulting from the drug or vaccine.  
They also are used to identify acute or persistent he-
patic damage resulting from hepatitis.  ALT and AST 
all showed a significant difference in the reference 
values for male and females, and the range was wider, 
unlike the often quoted values that is the same for 
males and females. The upper limits for the reference 
values for the liver function tests were higher than the 
quoted values.  This finding is similar to that of a study 
in an Urban South Indian community where gender 
differences were seen in the distribution of ALT and 
AST.  The upper limit for AST was found to be up to 
44 U/L in men and up to 39 U/L for women, as op-
posed to up to 37 U/L used in the lab.  That for ALT 
was 86 U/L for men and 75 U/L for women compared 
to 65 U/L used in the laboratory.15 Wide variations are 
known to occur in the transaminases and differences 
are also known to occur between males and females 
between whites and non whites.  The reasons for these 
differences are not known and it is possible that in our 
part of the world, occult hepatic insults from sub clini-
Table 2 Combined reference haematological and biochemical intervals for indices with similar distribu-
tion between male and female 
 

















3.4 (3.0,  3.7) 
27.5 (22.5, 31.7) 
4.2 (3.6, 5.1) 
24.4 (21.8, 26.0) 
 
8.8 (8.4, 9.4) 
66.5 (64.5, 68.7) 
25.3 (21.1, 28.3) 
60.7 (58.9, 70.2) 
Liver Function 
  Direct Bilirubin (mg/dL) 
  Total Bilirubin ( mg/dL) 











0.1 (0.1, 0.1) 
4.6 (4.0, 4.7) 
 
0.6 (0.5, 0.7) 
1.4 (1.1, 1.9) 
6.8 (6.5, 6.9) 
Urea & Electrolytes 
Blood Urea (mmol/L) 
Potassium (mmol/L) 










1.7 (1.3, 2.0) 
3.1 (3.0, 3.2) 
138.0 (137, 138) 
 
7.2 (6.9, 8.2) 
4.6 (4.5, 5.0) 
146 (145, 146) 
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cal viral infections or the usage of herbal preparations 
may contribute to the differences seen between the 
values reported here and those in standard clinical 
texts.  This has important implications for vaccine and 
other drug trials because using the quoted reference 
values without comparing it to reference intervals ap-
plicable to that population, volunteers could have been 
classified as having some liver dysfunction when in-
deed they may have a normal liver function for that 
population. This could lead to anxiety over volunteer 
laboratory results and unduly high reportage of adverse 
events among other things.  
 
Diet, physical environment and socio-economic condi-
tions all affect the physiology of a population, and 
hence measures of ‘normal’ physiological functions 
are expected to differ from population to population.  It 
is obvious from this study that there is the need to es-
tablish reference values that are applicable to specific 
populations rather than take a set of reference values 
determined for one population and apply it to another 
population , especially so for clinical trials.  
 
The reference values obtained from this study will 
guide us in screening and monitoring volunteers during 
the malaria vaccine clinical trials in Mampong. These 
values can also be embraced as guidelines in clinical 
management of patients at the Tetteh Quarshie Memo-
rial Hospital in Mampong. 
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